To further validate the molecular mechanism of MYLK-AS1 in HCC, we detected downstream molecules of EGFR/HER2-ERK signaling pathway of tumor tissues from the xenotransplantation model. This evidence concerns the gene MAPK1 and hepatocellular carcinoma.